Concepedia

Author

Carlos Sousa

National Institute of Health Dr. Ricardo JorgeORCID

Also Known As

Alexandra Costa, C Sousa, C.A.M. Sousa, C.A.M.D. Sousa, C.X. de Sousa, CARLOS ALBERTO PALMEIRA DE SOUSA, CARLOS ANTÔNIO COIMBRA SOUSA, CARLOS JÔNATHAS FOICINHA DE SOUSA, CLEANE CARVALHO SOUSA, Carlos Augusto Moreira de Sousa

55

Publications

467

Citations

13

H-Index

33

Concepts

All Affiliations

National Institute of Health Dr. Ricardo JorgeDireção Geral do TerritórioUniversidade do PortoUniversidade Nova de LisboaLusíada University of Porto
CS

About

Carlos Sousa is an author at National Institute of Health Dr. Ricardo Jorge specializing in medicine, emerging infectious diseases, and covid-19.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

103

2

Epidemiology

4

4

88

3

Public Health

3

3

49

4

Cell Biology

1

1

15

5

Global Health

1

1

15

Carlos Sousa

×

12

Publications

280

Citations

11

H-Index

YearCitations

Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021

Vítor Borges, Carlos Sousa, Luís Menezes,

Eurosurveillance

2021

85

Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants

Irina Kislaya, Eduardo Freire Rodrigues, Vítor Borges,

Emerging infectious diseases

2021

39

Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study

Pedro Vieira‐Baptista, AR Silva, Mariane Róvero Costa,

BJOG An International Journal of Obstetrics & Gynaecology

2021

26

Real-world assessment of the effect of impact of tumor size on pathological complete response rates in triple negative breast cancer after neoadjuvant chemotherapy

Bruno de Paula, Sanjeev Kumar, Fabiola Marques Morosini,

Chinese Clinical Oncology

2020

18

Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2)

André Peralta‐Santos, Eduardo Freire Rodrigues, Joana Moreno,

2022

17

SARS-CoV-2 BA.5 vaccine breakthrough risk and severity compared with BA.2: a case-case and cohort study using Electronic Health Records in Portugal

Irina Kislaya, Pedro Casaca, Vítor Borges,

2022

17

A cross-sectional study examining the expression of splice variants K-RAS4A and K-RAS4B in advanced non-small-cell lung cancer patients

Veronica Aran, Pedro Masson Domingues, Fabiane Carvalho de Macedo,

Lung Cancer

2017

15

Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughs

Irina Kislaya, Eduardo Freire Rodrigues, Vítor Borges,

2021

15

Cervista HPV HR Test for Cervical Cancer Screening: A Comparative Study in the Catalonian Population

Francesc Alameda, Leia Garrote, Sergi Mojal,

Archives of Pathology & Laboratory Medicine

2015

13

SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal

Vítor Borges, Joana Isidro, Nídia S. Trovão,

Communications Medicine

2022

13

Page 1